Genome-Based Therapeutics: Targeted Drug Discovery and Development: Workshop Summary

8:30–8:35 A.M.	WELCOMING REMARKS Wylie Burke, Roundtable Chair Professor and Chair, Department of Bioethics and Humanities, University of Washington

8:35–8:45 A.M.	CHARGE TO WORKSHOP SPEAKERS AND PARTICIPANTS Geoffrey Ginsburg Director, Center for Genomic Medicine, Duke University

8:45–10:15 A.M.	CURRENT LANDSCAPE Session Moderator: Aidan Power, Pfizer Inc.

8:45–9:00 A.M.	Current Use of Genetic and Genomic Strategies in Drug Development Nicholas Davies Partner, Pharmaceutical and Life Sciences Practice, PwC

9:00–9:15 A.M.	Economic Incentives for Genetic and Genomic Strategies Mark Trusheim Visiting Scientist and Executive-in-Residence, MIT Sloan School of Management; President, Co-Bio Consulting

9:15–9:30 A.M.	Perceived Challenges in Genomic-Based Drug Development Garret A. FitzGerald Professor of Medicine and Pharmacology and McNeil Professor in Translational Medicine and Therapeutics; Associate Dean for Translational Research; Chair, Department of Pharmacology; Director, Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine